Literature DB >> 21306733

Severe insomnia is associated with more severe presentation and greater functional deficits in depression.

Erin M O'Brien1, Iwona Chelminski, Diane Young, Kristy Dalrymple, Joshua Hrabosky, Mark Zimmerman.   

Abstract

Depression is among the most common reasons for seeking psychiatric treatment, and insomnia symptoms are common in the clinical picture of depression. The present study examines the clinical presentation and psychosocial functioning among depressed outpatients with severe symptoms of insomnia in comparison to depressed outpatients without severe insomnia symptoms. The present sample included 2900 treatment-seeking individuals, with 1057 patients having a principal diagnosis of major depressive disorder (MDD). All patients were evaluated using the Structured Clinical Interview for DSM-IV Disorders (SCID), Schedule for Affective Disorders (SADS), and self-report measures of mood and psychosocial functioning. SADS Insomnia ratings were used to determine the presence of severe insomnia symptoms. Clinical, demographic, and psychosocial variables were obtained from the SCID and self-report measures. Among the patients with MDD, 24.7% endorsed severe insomnia symptoms. These individuals were older at time of presentation, were less likely to be married, had a lower education level, had a longer duration of the current depressive episode, were rated as more severe on the CGI, had poorer current functioning via GAF, and had higher HAM-D 21 scores. After controlling for severity, MDD patients with severe insomnia symptoms had poorer social functioning over the past 5 years, though this did not reach the significance level of p < .01, and significantly lower scores on 3 of the 8 SF-36 subscales (p < 0.01). These findings indicate that severe insomnia symptoms are associated with poorer psychosocial functioning and a more severe clinical presentation in patients with MDD. This argues for addressing severe insomnia symptoms among depressed patients, either via behavioral treatment or pharmacologic treatment options.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21306733     DOI: 10.1016/j.jpsychires.2011.01.010

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  14 in total

1.  Eveningness and insomnia: independent risk factors of nonremission in major depressive disorder.

Authors:  Joey Wing Yan Chan; Siu Ping Lam; Shirley Xin Li; Mandy Wai Man Yu; Ngan Yin Chan; Jihui Zhang; Yun-Kwok Wing
Journal:  Sleep       Date:  2014-05-01       Impact factor: 5.849

2.  Molecular genetic overlap between posttraumatic stress disorder and sleep phenotypes.

Authors:  Mackenzie J Lind; Leslie A Brick; Philip R Gehrman; Laramie E Duncan; Bizu Gelaye; Adam X Maihofer; Caroline M Nievergelt; Nicole R Nugent; Murray B Stein; Ananda B Amstadter
Journal:  Sleep       Date:  2020-04-15       Impact factor: 5.849

3.  Chronotherapeutic treatments for depression in youth.

Authors:  Stephanie Gest; Martin Holtmann; Sarah Bogen; Carina Schulz; Benjamin Pniewski; Tanja Legenbauer
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-05-17       Impact factor: 4.785

4.  Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth.

Authors:  Graham J Emslie; Betsy D Kennard; Taryn L Mayes; Paul A Nakonezny; Lian Zhu; Rongrong Tao; Carroll Hughes; Paul Croarkin
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-01-18       Impact factor: 2.576

Review 5.  Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia).

Authors:  Amnon A Berger; Emily R Sottosanti; Ariel Winnick; Joseph Keefe; Elasaf Gilbert; Jamal Hasoon; Michael E Thase; Alan D Kaye; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2022-02-25

Review 6.  Efficacy and tolerability of Z-drug adjunction to antidepressant treatment for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Taro Kishi; Shinji Matsunaga; Nakao Iwata
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-06-18       Impact factor: 5.270

7.  Residual sleep disturbances in patients remitted from major depressive disorder: a 4-year naturalistic follow-up study.

Authors:  Shirley X Li; Siu P Lam; Joey W Y Chan; Mandy W M Yu; Yun-Kwok Wing
Journal:  Sleep       Date:  2012-08-01       Impact factor: 5.849

Review 8.  Agomelatine: an agent against anhedonia and abulia?

Authors:  J Thome; P Foley
Journal:  J Neural Transm (Vienna)       Date:  2013-12-06       Impact factor: 3.575

9.  Insomnia associated with depressive disorder: primary, secondary, or mixed?

Authors:  Ravi Gupta; Vivekananda Lahan
Journal:  Indian J Psychol Med       Date:  2011-07

10.  Impact of sleep disturbance on patients in treatment for mental disorders.

Authors:  Håvard Kallestad; Bjarne Hansen; Knut Langsrud; Torleif Ruud; Gunnar Morken; Tore C Stiles; Rolf W Gråwe
Journal:  BMC Psychiatry       Date:  2012-10-29       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.